Price Caps During Accelerated Approval Would Help Address Financial Toxicity for Patients, Jensen Says
A recent report from the HHS Office of the Inspector General (OIG) addressed challenges with the current accelerated approval pathway, which was created in 1992 to offer patients a way to gain access to novel therapies ahead of final results […]